Alexion Canada Since beginning our operations in Canada in 2009, Alexion has been working diligently to bring creative medicines to the millions of Canadians living with rare diseases. Our pioneering 30-year legacy, our scientific expertise and our commitment to patient-centric decision-making are the foundations of what we are today – a company with a mission to transform lives. Our Canadian team We know that people living with a rare disease and their families deserve our unwavering commitment and investment into finding and accessing therapies that help them live longer, fuller lives. Our presence in Canada has grown to over 200 employees and includes a global research and development hub, made up of highly skilled professionals responsible for conducting our clinical trials in Canada and around the world, as well as our dedicated and hardworking local teams that ensures our treatments reach those who need them. Together, we are driving patient impact locally and globally The Opportunity Reporting to the Franchise Lead –Rare Bone, Endocrine Disorders, and Rare Tumours, the Regional

📌 Regional Account Manager – Hpp (Hypophosphatasia) Rare Disease (Calgary)
🏢 AstraZeneca
📍 Calgary